» Authors » Stavroula Antonopoulou

Stavroula Antonopoulou

Explore the profile of Stavroula Antonopoulou including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 62
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kroustali V, Kanioura L, Resoulai E, Siopi M, Antonopoulou S, Meletiadis J
Microbiol Spectr . 2025 Jan; 13(3):e0248824. PMID: 39846759
The lack of clinical breakpoints and epidemiological cut-off values (ECOFFs) for antifungals prescribed for vulvovaginal candidiasis (VVC) make interpretation of antifungal susceptibility data difficult. This leads to empirical prescribing, poor...
2.
Kroustali V, Resoulai E, Kanioura L, Siopi M, Meletiadis J, Antonopoulou S
Mycoses . 2025 Jan; 68(1):e70026. PMID: 39834102
Background: The epidemiology of vulvovaginal candidiasis (VVC) in Greece remains poorly reported and outdated. Objectives: We therefore conducted a 2-year retrospective survey to assess the epidemiological aspects of the infection...
3.
Siopi M, Antonopoulou S, Mantzana P, Georgiou P, Vourli S, Protonotariou E, et al.
Med Mycol . 2022 Dec; 61(1). PMID: 36477291
Aspergillus spp. isolated from non-BAL cultures of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) patients may reflect colonization rather than infection. Sera (n = 181) from 49 adult ICU CAPA...
4.
Antonopoulou S, Cho S, Kesterke M, Kontogiorgos E, Korentzelos D
J Prosthet Dent . 2022 Aug; 128(3):488.e1-488.e9. PMID: 35970613
Statement Of Problem: Research-based storage guidelines for 3-dimensional (3D)-printed occlusal devices are lacking. Purpose: The purpose of this in vitro study was to investigate the dimensional stability of the internal...
5.
Meletiadis J, Paranos P, Georgiou P, Vourli S, Antonopoulou S, Michelaki A, et al.
Int J Antimicrob Agents . 2021 Sep; 58(5):106440. PMID: 34551356
Metallo-beta-lactamase (MBL)-producing Gram-negative bacteria are increasing worldwide and very few agents are active against these pathogens. Taniborbactam (formerly VNRX-5133) is a newly developed bicyclic boronate beta-lactamase inhibitor that directly inhibits...
6.
Athanasiou S, Pitsouni E, Antonopoulou S, Zacharakis D, Salvatore S, Falagas M, et al.
Neurourol Urodyn . 2020 Feb; 39(3):1026-1027. PMID: 32057126
No abstract available.
7.
De Bernardis F, Graziani S, Tirelli F, Antonopoulou S
Med Mycol . 2018 Mar; 56(suppl_1):26-31. PMID: 29538739
Vulvovaginal candidiasis is a common mucosal infection affecting a large proportion of women with some of them affected by recurrent often intractable forms of the disease. Thus, there is an...
8.
Tsiambas E, Ragos V, Metaxas G, Kyrousis G, Theohari T, Bouzalas L, et al.
J BUON . 2015 Nov; 20(5):1380-1. PMID: 26537092
No abstract available.
9.
Baka S, Kouskouni E, Antonopoulou S, Sioutis D, Papakonstantinou M, Hassiakos D, et al.
Urology . 2009 Apr; 74(1):62-6. PMID: 19371925
Objectives: To assess the prevalence of Ureaplasma urealyticum and Mycoplasma hominis in women experiencing chronic urinary symptoms. Methods: Urine, vaginal, and urethral samples obtained from 153 women presenting with chronic...
10.
Antonopoulou S, Aoun M, Alexopoulos E, Baka S, Logothetis E, Kalambokas T, et al.
Antimicrob Agents Chemother . 2009 Feb; 53(5):2181-4. PMID: 19223627
The activity of fenticonazole was studied against 260 West and Southeast European vulvovaginal candidiasis isolates, and low MICs were displayed. Fenticonazole was assessed by European Committee on Antimicrobial Susceptibility Testing...